IDx Competitors

When a five-year-old boy was blinded after a regular eye exam failed to spot a retinal detachment, his father made it his life’s work to help eye care professionals by revolutionising retinal imaging. Optos was founded by Douglas Anderson with the goal to make a patient-friendly device to capture a digital ultra-widefield image of the retina. Today, millions of patients around the world have benefited from optomap® retinal imaging. You will find optomap systems in many independent High Street optometrists, as well as eye clinics at Great Ormond Street Hospital in London and Harvard Medical Center in Massachusetts. Our core products produce high resolution optomap images of 82% or 200◦ of the retina, something no other imaging device is capable of in a single comfortable capture. The most recent innovation from Optos integrates ultra-widefield retinal imaging and image-guided Optical Coherence Tomography (OCT). This combined device facilitates the early detection, management and effective treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. More than 1,000 published and ongoing clinical trials as well as thousands of case studies and testimonials show the long-term value of optomap imaging and OCT in diagnosis, treatment planning, and patient engagement. As a division of Nikon Co. Ltd, Japan since 2015, Optos is approaching its 30th anniversary and proud to be recognized as a leading provider of devices to eye care professionals to provide a more complete approach to patient care.

Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform the quality, accessibility and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product LumineticsCore, an autonomous AI system FDA-authorized to diagnose diabetic retinopathy, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare. Digital Diagnostics is hiring! Learn more about our featured roles and other open positions here: www.digitaldiagnostics.com/careers/

...................................................................................................... Zebra in medicine terms means - a very surprising diagnostic. We are a next generation medical data research platform that will produce the needed amount of machine learning algorithms to provide scalable diagnostic to the next 1 billion people to join middle class. ....................................................................................................... Zebra Medical Vision’s Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease and offer preventative treatment pathways to improve patient care. The company’s AI solutions analyze millions of clinical imaging data in real time, detecting various medical indications, enabling it to be the only AI Medical Imaging company with such a wide range of products. Zebra Medical Vision is the only company that provides an All-In-One (AI1) Solution - access to all of Zebra’s AI solutions, integrated into radiologist workflow at an affordable, fixed annual fee. Zebra has secured multiple regulatory approvals, such as FDA and CE marks and is installed in hospitals globally. The company has raised $50 million in funding to date and was named in Fast Company’s Top-5 AI and Machine Learning company.